Hope is not Enough to Create a Reasonable Expectation of Success
In OSI Pharmaceuticals, LLC v. Apotex Inc., [2018-1925] (October 4, 2019), the Federal Circuit reversed the PTAB’s determination that claims 44-46 and 53 of U.S. Patent No. 6,900,221 on the use of erlotinib on non smallcell lung cancer (NSCLC) would … Continue reading Hope is not Enough to Create a Reasonable Expectation of Success
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed